Advertisement
AMGN vs RFDA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Hold and RFDA is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMGN’s FA Score shows that 1 FA rating(s) are green while.
- AMGN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMGN’s TA Score shows that 4 TA indicator(s) are bullish.
- AMGN’s TA Score: 4 bullish, 5 bearish.
Price Growth
AMGN (@Pharmaceuticals: Major) experienced а +0.13% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.91%. For the same industry, the average monthly price growth was +2.58%, and the average quarterly price growth was +20.22%.
Reported Earning Dates
AMGN is expected to report earnings on Nov 04, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (+0.91% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
AMGN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 24 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 38 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 61 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AMGN | RFDA | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 72% |
| Stochastic ODDS (%) | 2 days ago 53% | 2 days ago 70% |
| Momentum ODDS (%) | 2 days ago 48% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 64% | 2 days ago 60% |
| TrendWeek ODDS (%) | 2 days ago 59% | 2 days ago 69% |
| TrendMonth ODDS (%) | 2 days ago 55% | 2 days ago 86% |
| Advances ODDS (%) | 3 days ago 56% | 4 days ago 85% |
| Declines ODDS (%) | 23 days ago 52% | 2 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 60% | 2 days ago 85% |
| Aroon ODDS (%) | 2 days ago 54% | 2 days ago 85% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| REZ | 84.17 | 0.74 | +0.89% |
| iShares Residential & Multisector RE ETF | |||
| ACWI | 138.63 | 0.55 | +0.40% |
| iShares MSCI ACWI ETF | |||
| HYXF | 47.32 | 0.17 | +0.36% |
| iShares ESG Advanced Hi Yld Corp Bd ETF | |||
| IBIJ | 26.26 | -0.06 | -0.25% |
| iShares iBonds Oct 2033 Term Tips ETF | |||
| USNG | 27.61 | -0.20 | -0.74% |
| Amplify Samsung U.S. Natrl Gas InfrasETF | |||
AMGN and
Correlation & Price change
A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with ABBV. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then ABBV could also see price increases.
| Ticker / NAME | Correlation To AMGN | 1D Price Change % | ||
|---|---|---|---|---|
| AMGN | 100% | +1.01% | ||
| ABBV - AMGN | 59% Loosely correlated | +1.19% | ||
| PFE - AMGN | 56% Loosely correlated | +1.16% | ||
| NVS - AMGN | 54% Loosely correlated | +0.50% | ||
| BIIB - AMGN | 53% Loosely correlated | +0.52% | ||
| GSK - AMGN | 53% Loosely correlated | +0.32% | ||
More | ||||
RFDA and
Correlation & Price change
A.I.dvisor tells us that RFDA and HUM have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RFDA and HUM's prices will move in lockstep.
| Ticker / NAME | Correlation To RFDA | 1D Price Change % | ||
|---|---|---|---|---|
| RFDA | 100% | +0.50% | ||
| HUM - RFDA | 14% Poorly correlated | +2.89% | ||
| KO - RFDA | 13% Poorly correlated | +1.26% | ||
| MRK - RFDA | 11% Poorly correlated | +1.04% | ||
| AMGN - RFDA | 11% Poorly correlated | +1.01% | ||
| QCOM - RFDA | 10% Poorly correlated | -0.38% | ||
More | ||||